We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
-2.81%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$93.9M
Cap. Flow
+$112M
Cap. Flow %
33.58%
Top 10 Hldgs %
28.51%
Holding
174
New
26
Increased
81
Reduced
34
Closed
27

Top Buys

Rank Stock Value
1
TEX icon
Terex
TEX
+$6.33M
2
HRI icon
Herc Holdings
HRI
+$6.32M
3
TKR icon
Timken Company
TKR
+$4.82M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
5
VMC icon
Vulcan Materials
VMC
+$4.35M

Top Sells

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$7.13M
2
FLR icon
Fluor
FLR
+$5.32M
3
FSS icon
Federal Signal
FSS
+$5.11M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.53M
5
ASND icon
Ascendis Pharma A/S
ASND
+$1.85M

Sector Composition

Rank Sector Weight
1 Industrials 43.38%
2 Healthcare 33.02%
3 Utilities 7.31%
4 Technology 5.91%
5 Financials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFL icon
51
GFL Environmental
GFL
$14.3B
$2.24M 0.67%
+46,459
New +$2.11M
HON icon
52
Honeywell
HON
$71.3B
$2.1M 0.63%
+10,510
New +$2.13M
FICO icon
53
Fair Isaac
FICO
$29.2B
$2.09M 0.62%
1,133
+612
+117% +$1.13M
PPL
54
PPL Corp
PPL
$27B
$2.04M 0.61%
+56,421
New +$1.91M
SHW icon
55
Sherwin-Williams
SHW
$81.7B
$2.02M 0.6%
5,773
+3,420
+145% +$1.2M
GMAB icon
56
Genmab
GMAB
$17.6B
$2.01M 0.6%
102,749
+43,814
+74% +$919K
XEL icon
57
Xcel Energy
XEL
$49.2B
$1.99M 0.59%
+28,077
New +$1.91M
CRNX icon
58
Crinetics Pharmaceuticals
CRNX
$8.88B
$1.97M 0.59%
58,807
+874
+2% +$32.6K
APH icon
59
Amphenol
APH
$186B
$1.94M 0.58%
29,561
+23,793
+413% +$1.62M
ONC
60
BeOne Medicines Ltd
ONC
$32.4B
$1.93M 0.58%
7,083
+834
+13% +$195K
SMMT icon
61
Summit Therapeutics
SMMT
$10.7B
$1.89M 0.57%
98,111
+71,470
+268% +$1.43M
ICE icon
62
Intercontinental Exchange
ICE
$79B
$1.87M 0.56%
10,825
+3,397
+46% +$557K
ACLX
63
DELISTED
Arcellx
ACLX
$1.87M 0.56%
28,450
+20,982
+281% +$1.42M
BPMC
64
DELISTED
Blueprint Medicines
BPMC
$1.86M 0.55%
20,972
-1,502
-7% -$147K
BSX icon
65
Boston Scientific
BSX
$65.4B
$1.84M 0.55%
18,206
-2,288
-11% -$230K
LEGN icon
66
Legend Biotech
LEGN
$4.31B
$1.76M 0.53%
52,008
+40,646
+358% +$1.46M
POWL icon
67
Powell Industries
POWL
$8.48B
$1.76M 0.53%
30,996
+24,948
+413% +$1.74M
ALNY icon
68
Alnylam Pharmaceuticals
ALNY
$35.7B
$1.75M 0.52%
6,475
-9,848
-60% -$2.53M
ARGX icon
69
argenx
ARGX
$53.8B
$1.73M 0.52%
2,922
-1,676
-36% -$1.06M
CPRT icon
70
Copart
CPRT
$25.6B
$1.7M 0.51%
30,080
+17,860
+146% +$1.01M
CME icon
71
CME Group
CME
$88.5B
$1.7M 0.51%
6,400
+3,800
+146% +$937K
INTU icon
72
Intuit
INTU
$79.6B
$1.67M 0.5%
2,720
+1,615
+146% +$970K
MSCI icon
73
MSCI
MSCI
$45.8B
$1.64M 0.49%
2,901
+1,710
+144% +$994K
VRT icon
74
Vertiv
VRT
$111B
$1.64M 0.49%
22,673
+18,249
+413% +$1.94M
MREO
75
Mereo BioPharma
MREO
$49.5M
$1.47M 0.44%
654,666
-235,882
-26% -$667K
1 2
3
4 5

Similar funds

DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $3.08B AUM 12.02% 1-Year Est. Return

Tema ETFs's Q1 2025 Portfolio in Review

As of Q1 2025, Tema ETFs held 174 positions worth $335M, up 39% from $241M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tema ETFs deployed $112M of net new capital in Q1 2025, opening 26 new positions and adding to 81 existing holdings. Its largest new stake was Bristol-Myers Squibb: 75,050 shares worth $4.58M.

By sector, the portfolio is most concentrated in Industrials at 43% of assets, down from 46% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $2.53M trimmed.

  • Tema ETFs's largest Q1 2025 buy was Bristol-Myers Squibb: 75,050 shares worth $4.58M.
  • Tema ETFs added most to Terex in Q1 2025, an estimated $6.33M increase.
  • Tema ETFs's biggest Q1 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.53M.
  • Tema ETFs fully exited Primoris Services in Q1 2025, selling an estimated $7.13M.
  • Tema ETFs's ten largest holdings make up 29% of its $335M portfolio in Q1 2025.
  • Tema ETFs opened 26 new positions and closed 27 in Q1 2025.
  • Tema ETFs's portfolio value rose 39% quarter-over-quarter to $335M.

Based on Tema ETFs's 13F filing for Q1 2025, filed 14 May 2025.